Reimagining Drug
Discovery.
Transforming Lives.

At Evolvia BioPharma, we combine AI, deep biology, and medicinal chemistry to discover and develop best-in-class medicines for patients.

Meet the Team

Evolving Science. Evolving Ownership. Evolving Medicine.

Evolvia BioPharma is designed as a living biopharmaceutical organization where the best contributors can emerge from anywhere, solve critical problems, earn ownership, and shape the company through impact.

Evolving science

AI-driven discovery, computational design, CRO synthesis, biological validation, and continuous optimization.

Fully outsourced execution

No unnecessary laboratories or fixed infrastructure. Capital is deployed directly into experiments and knowledge creation.

Evolving ownership

Ownership is earned through verified scientific, technical, operational, legal, financial, and strategic contribution.

Mission

To reinvent pharmaceutical innovation by creating a self-evolving, AI-enabled, globally distributed company where the world's best minds collaborate to create transformative medicines and earn ownership through impact.

Vision

A future where pharmaceutical companies are not defined by buildings, borders, or predetermined organizations, but by evolving networks of global intelligence dedicated to creating transformative medicines.

Therapeutic portfolio

Aging & longevity

Therapies targeting biological mechanisms of aging and age-associated decline.

Oncology

Next-generation cancer therapeutics using AI-guided discovery and outsourced validation.

Cardiometabolic medicine

PCSK9 cholesterol control and GLP-1 metabolic health programs.

Current development status

Computational discoveryInitial AI-driven design and prioritization completed across therapeutic directions.
CRO synthesisLead molecules are being prepared for synthesis through external contract research execution.
External validationExperimental validation strategy is being organized through specialized partners and laboratories.